The Significance of NAD+ Biosynthesis Alterations in Acute Kidney Injury
Acute kidney injury (AKI) is a serious and highly prevalent disease, yet only supportive treatment is available. Nicotinamide adenine dinucleotide (NAD+) is a cofactor necessary for adenosine triphosphate (ATP) production and cell survival. Changes in renal NAD+ biosynthesis and energy utilization are features of AKI. Targeting NAD+ as an AKI therapy shows promising potential. However, the pursuit of NAD+-based treatments requires deeper understanding of the unique drivers and effects of the NAD+ biosynthesis derangements that arise in AKI.
Source: Seminars in Nephrology - Category: Urology & Nephrology Authors: Amanda J. Clark, Marie Christelle Saade, Samir M. Parikh Source Type: research
More News: Urology & Nephrology